Assessment of the frequency of different Borrelia burgdorferi sensu lato species in patients with Lyme borreliosis from north-east Poland by studying preferential serologic response and DNA isolates

• Autorzy: Grygorczuk S. , Peter O. , Kondrusik M. , Moniuszko A. , Zajkowska J. , Dunaj J. , Zukiewicz-Sobczak W. , Pancewicz S.
• Języki publikacji: EN

Abstrakty

EN

Introduction and objective. Several Borrelia burgdorferi sensu lato species cause Lyme borreliosis throughout Europe and their geographic distribution may influence clinical manifestations of the disease. In Poland, Lyme borreliosis presents mainly with neurologic and cutaneous symptoms, while clinically overt arthritis is rare. The presented study investigates the prevalence of B. burgdorferi s.l. genospecies in a group of patients with different clinical forms and stages of Lyme borreliosis in north-east of Poland. This has not previously been studied. Material and methods. Preferential reactivity towards different B.burgdorferi s.l. species was investigated with a previously validated immunoblot assay in sera of 33 patients with disseminated Lyme borreliosis: 10 with neuroborreliosis, 6 with acrodermatitis chronica atrophicans and 17 with osteoarticular symptoms. Also typed were B.burgdorferi s.l. DNA isolated from the skin and synovial fluid of 7 patients with erythema migrans, acrodermatitis chronic atrophicans and arthritis. Results. Preferential reactivity was detected in 30 out of 33 serum samples. Of these, 25 reacted preferentially with B.afzelii, 3 with B. garinii and 2 with B. burgdorferi ss. B.burgdorferi DNA was isolated from all studied samples and typed as B.afzelii in 5. In a patient with acrodermatitis chronica atrophicans studied with both methods simultaneously, B.afzelii was identified by both genotyping and serotyping. Conclusions. Both methods gave consistent results, indicating B.afzelii as the main agent of all the clinical forms of the Lyme borreliosis in the study area.

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2013
• Tom: 20
• Numer: 1
• Opis fizyczny: p.21-29,fig.,ref.

Twórcy

autor

Grygorczuk S.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

autor

Peter O.

• Central Institute of Valais Hospital, Infectious Diseases Department, Sion, Switzerland

autor

Kondrusik M.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

autor

Moniuszko A.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

autor

Zajkowska J.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

autor

Dunaj J.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

autor

Zukiewicz-Sobczak W.

• Department of Alergology and Environmental Hazards, Institute of Rural Health, Lublin, Poland

autor

Pancewicz S.

• Department of Infectious Diseases and Neuroinfections, Medical University in Białystok, Poland

Bibliografia

• 1. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol MedMicrobiol. 2007; 49(1): 13-21.
• 2. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ. Steere AC, Klempner MS, et al. The clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society ofAmerica. Clin Infect Dis. 2006; 43(9): 1089-1133.
• 3. Jones KL, Muellegger RR, Means TK, Lee M, Glickstein LJ, Damle N, et al. Higher nRNA levels of chemokines and cytokines associatedwith macrophage activation in erythema migrans skin lesions inpatients from the United States than in patients from Austria withLyme borreliosis. Clin Infect Dis. 2008; 46(1): 85-92.
• 4. Strle F, Ružić-Sabljić E, Cimperman J, Lotrič-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borreliaafzelii isolated from cerebrospinal fluid. Clin Infect Dis. 2006; 43(6):704-710.
• 5. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migranscaused by Borrelia burgdorferi sensu stricto in New York State andby Borrelia afzelii in Slovenia. Ann Intern Med. 1999; 130(1): 32-36.
• 6. Saint Girons I, Gern I, Gray JS, Guy EC, Korenberg E, Nuttall PA, et al. Identification of Borrelia burgdorferi sensu lato species in Europe.Zentralbl Bakteriol. 1998; 287(3): 190-195.
• 7. Hubalek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Europ J Epidemiol. 1997;13: 951-957.
• 8. Kirstein F, Rijpkema S, Molkenboer M, Gray JS. The distribution and revalence of B. burgdorferi genomospecies in Ixodes ricinus ticks in Ireland. Eur J Epidemiol. 1997; 13(8): 67-72.
• 9. Oehme R, Hartelt K, Backe H, Brockmann S, Kimmig P. Foci of tickborne diseases in southwest Germany. Int J Med Microbiol. 2002; 291(Suppl 33): 22-29.
• 10. Stanek G, Reiter M. The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin Microb Infect Dis. 2011; 17(4):487-493.
• 11. Dam van AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are ssociated with distinct clinical manifestations of Lyme borreliosis.Clin Infect Dis. 1993; 17(4): 708-717.
• 12. Demaerschalck I, Ben Messaud A, de Kesel M, Hoyois B, Lobet Y, Hoet P, et al. Simultaneous presence of different Borrelia burgdorferigenospecies in biological fluids of Lyme disease patients. J ClinMicrobiol. 1995; 33(3): 602-608.
• 13. Richter D, Schlee DB, Allgöwer R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hostsin Central Europe. Appl Environ Microbiol. 2004; 70(11): 6414-6419.
• 14. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, Noordhoek GT, Plantinga G, Schouls LM, et al. Detection of Borrelia afzelii, Borrelia burgdorferisensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsiesof patients with erythema migrans and acrodermatitis chronicaatrophicans. Clin Microbiol Infect. 1997; 3(1): 109-116.
• 15. Stefanoff P, Rosińska M, Zieliński A. Epidemiology of tick-borne diseases in Poland. Przegl Epidemiol. 2006; 60(Suppl): 151-159(in Polish).
• 16. Stańczak J, Kubica-Biernat B, Racewicz M, Kruminis-Lozowska W, Kur J. Detection of three genospecies of Borrelia burgdorferi sensulato in Ixodes ricinus ticks collected in different regions of Poland. IntJ Med Microbiol. 2000; 290(6): 559-566.
• 17. Cisak E, Wójcik-Fatla A, Stojek NM, Chmielewska-Badora J, Zwoliński J, Buczek A, et al. Prevalence of Borrelia burgdorferi genospecies in Ixodesricinus ticks from Lublin region (eastern Poland). Ann Agric EnvironMed. 2006; 13(2): 301-306.
• 18. Lenčaková D, Hizo-Teufel C, Pet’ko B, Schulte-Spechtel U, Stanko M, Wilske B, et al. Prevalence of Borrelia burgdorferi s.l. OspA types in Ixodes ricinus ticks from selected localities in Slovakia and Poland. Int J Med Microbiol. 2006;296 (Suppl 40): 108-118.
• 19. Kondrusik M, Dunaj J, Pancewicz SA, Zajkowska JM, Moniuszko A, Czupryna P, et al. Evaluation of Borrelia spp. prevalence andgenospecies distribution among Ixodes ricinus ticks using Reverse-Line blot hybridization method. 12th International Conference onLyme Borreliosis and Other Tick-Borne Diseases, September 26-29,2010, Ljubljana, Slovenia. Abstracts. P45, 62.
• 20. Norman GL, Antig JM, Bigaignon G, Hogrefe WR. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii and28 B. afzelii Western blots (immunoblots). J Clin Microbiol. 1996; 34(7):1732-1738.
• 21. Nygård K, Brantæter AB, Mehl R. Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Euro Surveill. 2005; 10(10): 235-238.
• 22. Ryffel K, Péter O, Rutti B, Suard A, Dayer E. Scored antibody reactivity determined by immunobloting shows an association between clinical anifestation and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. valaisiana in humans. J Clin Microbiol. 1999; 37(12): 4086-4092.
• 23. Péter O, Bretz AG, Postic D, Dayer E. Association of distinct species of Borrelia burgdorferi sensu lato with neuroborreliosis in Switzerland.Clin Microbiol Infect. 1997; 3(4): 423-431.
• 24. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005; 18(3): 484-509.
• 25. Rauter C, Oehme R, Diterich I, Engele M, Hartnung T. Distribution of clinically relevant Borrelia genospecies in ticks associated by a novel,single-run, real-time PCR. J Clin Microbiol. 2002; 40(1): 36-43.
• 26. Ranka R, Bormane A, Salmina K, Baumanis V. Identification of three clinically relevant Borrelia burgdorferi sensu lato genospecies by PCR-restriction fragment length polymorphism analysis of 16S-23Sribosomal DNA spacer amplicons. J Clin Microbiol. 2004; 42(14):1444-1449.
• 27. Galdakaite E, Radzijevskaja J, Paulauskas A. Identification of Borrelia burgdorferi s.l. and Anaplasma phagocytophilum in I. ricinus and I. persulcatus ticks collected in Baltic countries. XI International Symposium on Tick-Borne Diseases 2011 (Formerly IPS). Programand Abstracts. P20; 88.
• 28. Wormser GP, Brisson D, Liveris D, Hanincová K, Sandigursky S, Nowakowski J, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J InfectDis. 2008; 198(9): 1358-1364.
• 29. Steere AC. Clinical definitions and differential diagnosis of Lyme arthritis. Scand J Infect Dis. 1991; 23(Suppl.77): 51-4.

Uwagi

rekord w opracowaniu